Skip to content
OpenCapital
Get started

KORU Medical Systems KRMD Work-in-process and raw materials

Other financials

Income statement

See full
Revenue$11.8M+22.1%
Gross profit$7.2M+19.6%
Operating income-$864.9K+30.5%
Net income-$807.1K+30.8%
EPS (diluted)-$0.02+33.3%

Balance sheet

See full
Cash & equivalents$8.8M+0.4%
Total debt$3.5M-2.8%
Total equity$16.9M+3.5%
Total assets$28.6M+5.1%

Cash flow

See full
Operating cash flow$14.7K+106%
CapEx$46.2K-89.6%
Free cash flow-$31.5K+95.4%

Valuation

See full
Market cap$206.24M+24.9%
Enterprise value$200.96M+25.1%
P/S4.8×+0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin-6%-2.3pp
Net margin-5.3%-2.1pp
FCF margin-37.1%+23.7pp

Returns & leverage

See full
Return on equity-13.7%-4.8pp
Debt / equity0.2×0.0×
Current ratio2.3×-0.1×

Where this comes from

Reported directly by KORU Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:InventoryWorkInProcessAndRawMaterials.

The official record: KORU Medical Systems’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KORU Medical Systems's work-in-process and raw materials.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KORU Medical Systems's work-in-process and raw materials?
KORU Medical Systems (KRMD) reported work-in-process and raw materials of $732.51K in Q4 2025.
How has KORU Medical Systems's work-in-process and raw materials changed year-over-year?
KORU Medical Systems's work-in-process and raw materials decreased by 11.5% year-over-year, from $827.77K to $732.51K.
What is the long-term trend for KORU Medical Systems's work-in-process and raw materials?
Over 5 years (2020 to 2025), KORU Medical Systems's work-in-process and raw materials has grown at a -20.3% compound annual growth rate (CAGR), from $2.28M to $732.51K.